Rapiscan
Rapiscan is a medicine containing Regadenosonum, listed in the Romanian national register of medicines for human use with 1 presentation.
General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.
At a glance
- Active substance
- REGADENOSONUM
- ATC code
- C01EB21 Cardiovascular system
- Therapeutic action
- ALTE MEDICAMENTE PENTRU AFECTIUNI CARDIACE ALTE MEDICAMENTE PENTRU AFECTIUNI CARDIACE
- Prescription
- Prescription required (register code PR)
- Marketing authorisation holder
- GE HEALTHCARE AS - NORVEGIA
- Manufacturer
- MILLMOUNT HEALTHCARE LIMITED - IRLANDA
- Pharmaceutical form
- SOL. INJ.
Presentations and codes
CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.
| CIM code | Form | Strength | Pack | Prescription | Authorisation | Shelf life |
|---|---|---|---|---|---|---|
| W64487001 | SOL. INJ. | 80micrograme/ml | Cutie cu 1 flac. x 5 ml sol. inj. (400 mg regadenoson) | PR | 643/2010/01 | 4 ani |
What it is used for
Anpheros does not have a page with official indications for this substance yet.
The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Rapiscan” in the national register.
Scan the box in Anpheros
In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.
Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.